A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

NCT04683406 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A

Interventions

DRUG: ZSP1273 600 mg
DRUG: Placebo to Oseltamivir
DRUG: Oseltamivir(oral)
DRUG: Placebo to ZSP1273

Sponsor

Guangdong Raynovent Biotech Co., Ltd